Effects of Atypical Kappa-opioid Receptor Agonists on Intrathecal Morphine-induced Itch and Analgesia in Primates

Overview

Journal J Pharmacol Exp Ther

Specialty Pharmacology

Date 2008 Oct 10

PMID 18842704

Citations 41

Authors

Mei-Chuan Ko

Stephen M Husbands

Affiliations

Soon will be listed here.

Abstract

Itch/pruritus is the most common side effect associated with spinal administration of morphine given to humans for analgesia. The aim of this study was to investigate the effectiveness of kappa-opioid receptor (KOR) agonists with diverse chemical structures as antipruritics and to elucidate the receptor mechanism underlying the antipruritic effect in monkeys. In particular, previously proposed non-KOR-1 agonists, including nalfurafine [TRK-820, 17-cyclopropylmethyl-3,14 beta-dihydroxy-4,5 alpha-epoxy-6 beta-[N-methyl-trans-3-(3-furyl)acrylamido]morphinan], bremazocine [(+/-)-6-ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropy)-methyl]-11,11-dimethyl-2,6-methano-3-benzazocin-8-ol], and GR 89696 [4-[(3,4-dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-1-piperazinecarboxylic acid methyl ester] were studied in various behavioral assays for measuring itch/scratching, analgesia, and respiratory depression. Systemic administration of nalfurafine (0.1-1 microg/kg), bremazocine (0.1-1 microg/kg), or GR 89696 (0.01-0.1 microg/kg) dose-dependently attenuated intrathecal morphine (0.03 mg)-induced scratching responses without affecting morphine antinociception. The combination of intrathecal morphine with these KOR agonists did not cause sedation. In addition, pretreatment with effective antiscratching doses of nalfurafine, bremazocine, or GR 89696 did not antagonize systemic morphine-induced antinociception and respiratory depression. The dose-addition analysis revealed that there is no subadditivity for nalfurafine in combination with morphine in the antinociceptive effect. Furthermore, the KOR antagonist study revealed that antiscratching effects of both nalfurafine and a prototypical KOR-1 agonist, U-50488H [trans-(+/-)-3,4-dichloro-N-methyl-N-(2-[1-pyrrolidinyl]-cyclohexyl)-benzeneacetamide], could be blocked completely by a selective KOR antagonist, nor-binaltorphimine (3 mg/kg). These findings suggest that the agonist action on KOR mainly contributes to the effectiveness of these atypical KOR agonists as antipruritics, and there is no evidence for KOR subtypes or mu-opioid antagonist action underlying the effects of these KOR agonists. This mechanism-based study further supports the clinical potential of KOR agonists as antipruritics under the context of spinal opioid analgesia.

Citing Articles

Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder.

Huang B, Ma H, Pagare P, Li M, Mendez R, Gillespie J ACS Pharmacol Transl Sci. 2024; 7(12):4165-4182.

PMID: 39698260 PMC: 11651181. DOI: 10.1021/acsptsci.4c00593.

Kappa opioids inhibit spinal output neurons to suppress itch.

Sheahan T, Warwick C, Cui A, Baranger D, Perry V, Smith K Sci Adv. 2024; 10(39):eadp6038.

PMID: 39321286 PMC: 11423883. DOI: 10.1126/sciadv.adp6038.

Identification of a convergent spinal neuron population that encodes itch.

Sheahan T, Warwick C, Cui A, Baranger D, Perry V, Smith K bioRxiv. 2023; .

PMID: 37873278 PMC: 10592866. DOI: 10.1101/2023.09.29.560205.

Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeys.

Zamarripa C, Huskinson S, Townsend E, Prisinzano T, Blough B, Rowlett J Psychopharmacology (Berl). 2023; 241(2):305-314.

PMID: 37870564 DOI: 10.1007/s00213-023-06486-5.

Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeys.

Huskinson S, Platt D, Smith Z, Doyle W, Zamarripa C, Dunaway K Drug Alcohol Depend. 2023; 252:110953.

PMID: 37734282 PMC: 10615792. DOI: 10.1016/j.drugalcdep.2023.110953.

References

Ko M, Johnson M, Butelman E, Willmont K, Mosberg H, Woods J . Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys. J Pharmacol Exp Ther. 1999; 291(3):1113-20. PMC: 2939326. View

Ko M, Naughton N . An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology. 2000; 92(3):795-805. PMC: 1937505. DOI: 10.1097/00000542-200003000-00023. View

Kishioka S, Paronis C, Woods J . Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys. Eur J Pharmacol. 2000; 398(1):121-30. DOI: 10.1016/s0014-2999(00)00279-x. View

Endoh T, Tajima A, Izumimoto N, Saitoh A, Suzuki T, Narita M . TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys. Jpn J Pharmacol. 2001; 85(3):282-90. DOI: 10.1254/jjp.85.282. View

Kamei J, Nagase H . Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol. 2001; 418(1-2):141-5. DOI: 10.1016/s0014-2999(01)00941-4. View

Butelman E, Ko M, Traynor J, Vivian J, Kreek M, Woods J . GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. J Pharmacol Exp Ther. 2001; 298(3):1049-59. View

Li J, Li J, Chen C, Zhang F, Liu-Chen L . Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells. Mol Pharmacol. 2001; 61(1):73-84. DOI: 10.1124/mol.61.1.73. View

Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T . Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol. 2002; 435(2-3):259-64. DOI: 10.1016/s0014-2999(01)01588-6. View

Mizoguchi H, Hung K, Leitermann R, Narita M, Nagase H, Suzuki T . Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice. Eur J Pharmacol. 2003; 461(1):35-9. DOI: 10.1016/s0014-2999(03)01299-8. View

10.

Ko M, Lee H, Song M, Sobczyk-Kojiro K, Mosberg H, Kishioka S . Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. J Pharmacol Exp Ther. 2003; 305(1):173-9. DOI: 10.1124/jpet.102.044909. View

11.

Ko M, Willmont K, Lee H, Flory G, Woods J . Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Res. 2003; 982(1):38-44. PMC: 2863110. DOI: 10.1016/s0006-8993(03)02938-x. View

12.

DeBalli P, Breen T . Intrathecal opioids for combined spinal-epidural analgesia during labour. CNS Drugs. 2003; 17(12):889-904. DOI: 10.2165/00023210-200317120-00003. View

13.

Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T . Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol. 2003; 477(1):29-35. DOI: 10.1016/j.ejphar.2003.08.007. View

14.

Lee H, Naughton N, Woods J, Ko M . Characterization of scratching responses in rats following centrally administered morphine or bombesin. Behav Pharmacol. 2003; 14(7):501-8. PMC: 1810379. DOI: 10.1097/01.fbp.0000095082.80017.0f. View

15.

Liu-Chen L . Agonist-induced regulation and trafficking of kappa opioid receptors. Life Sci. 2004; 75(5):511-36. DOI: 10.1016/j.lfs.2003.10.041. View

16.

Ko M, Song M, Edwards T, Lee H, Naughton N . The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther. 2004; 310(1):169-76. DOI: 10.1124/jpet.103.061101. View

17.

Wakasa Y, Fujiwara A, Umeuchi H, Endoh T, Okano K, Tanaka T . Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Life Sci. 2004; 75(24):2947-57. DOI: 10.1016/j.lfs.2004.05.033. View

18.

Cousins M, Mather L . Intrathecal and epidural administration of opioids. Anesthesiology. 1984; 61(3):276-310. View

19.

Rawal N, Schott U, Dahlstrom B, Inturrisi C, Tandon B, SJOSTRAND U . Influence of naloxone infusion on analgesia and respiratory depression following epidural morphine. Anesthesiology. 1986; 64(2):194-201. DOI: 10.1097/00000542-198602000-00011. View

20.

Gmerek D, Dykstra L, Woods J . Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. J Pharmacol Exp Ther. 1987; 242(2):428-36. View